logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
16/04/2026
Standard & Poor's: stable outlook reflects its view that the Australian Securities Exchange will maintain its dominant market position in Australia.
Latest
3 m ago
Elliott, a radical investment institution, bought shares in Daqin Industrial, causing the stock price to surge by 14%.
4 m ago
Anhui Aide Xia Automobile Core Component Production Base Project Put into Operation
5 m ago
CITIC Futures: Precious metals supported by geopolitical factors suggest that it is advisable to buy on dips for long-term layout. Pay attention to the allocation value in a "stagflation-like" environment.
6 m ago
New York silver futures rose 1% intraday and are currently trading at $80.47 per ounce.
6 m ago
On April 16th, the world's first biased GLP-1 receptor agonist, Semaglutide injection, has started pre-booking on Alibaba Health. In February this year, Pfizer China and Hangzhou Xianwei Da Biotech announced a commercial strategic cooperation agreement on the new generation of biased GLP-1 receptor agonist Semaglutide injection. Currently, Semaglutide has completed strategic deployment for the dual indications of "diabetes + weight loss" (Securities Times).
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.